Davies O Kimanga1, Samuel Ogola, Mamo Umuro, Anne Ng'ang'a, Lucy Kimondo, Patrick Murithi, James Muttunga, Wanjiru Waruiru, Ibrahim Mohammed, Shahnaaz Sharrif, Kevin M De Cock, Andrea A Kim. 1. *The National AIDS and Sexually Transmitted Infection (STI) Control Programme, Ministry of Health, Nairobi, Kenya; †Kenya National Bureau of Statistics, Nairobi, Kenya; ‡National Public Health Laboratory Services, Ministry of Health, Nairobi, Kenya; §The National Council for Population and Development, Nairobi, Kenya; ‖National AIDS Control Council, Nairobi, Kenya; ¶Kenya Medical Research Institute, Nairobi, Kenya; #Global Health Sciences, University of California, San Francisco, San Francisco, CA; **Ministry of Health, Nairobi, Kenya; and ††Division of Global HIV/AIDS, Center for Global Health, US Centers for Disease Control and Prevention, Nairobi, Kenya.
Abstract
BACKGROUND: Enhanced HIV surveillance using demographic, behavioral, and biologic data from national surveys can provide information to evaluate and respond to HIV epidemics efficiently. METHODS: From October 2012 to February 2013, we conducted a 2-stage cluster sampling survey of persons aged 18 months to 64 years in 9 geographic regions in Kenya. Participants answered questionnaires and provided blood for HIV testing. We estimated HIV prevalence, HIV incidence, described trends in HIV prevalence over the past 5 years, and identified factors associated with HIV infection. This analysis was restricted to persons aged 15-64 years. RESULTS: HIV prevalence was 5.6% [95% confidence interval (CI): 4.9 to 6.3] in 2012, a significant decrease from 2007, when HIV prevalence, excluding the North Eastern region, was 7.2% (95% CI: 6.6 to 7.9). HIV incidence was 0.5% (95% CI: 0.2 to 0.9) in 2012. Among women, factors associated with undiagnosed HIV infection included being aged 35-39 years, divorced or separated, from urban residences and Nyanza region, self-perceiving a moderate risk of HIV infection, condom use with the last partner in the previous 12 months, and reporting 4 or more lifetime number of partners. Among men, widowhood, condom use with the last partner in the previous 12 months, and lack of circumcision were associated with undiagnosed HIV infection. CONCLUSIONS: HIV prevalence has declined in Kenya since 2007. With improved access to treatment, HIV prevalence has become more challenging to interpret without data on new infections and mortality. Correlates of undiagnosed HIV infection provide important information on where to prioritize prevention interventions to reduce transmission of HIV in the broader population.
BACKGROUND: Enhanced HIV surveillance using demographic, behavioral, and biologic data from national surveys can provide information to evaluate and respond to HIV epidemics efficiently. METHODS: From October 2012 to February 2013, we conducted a 2-stage cluster sampling survey of persons aged 18 months to 64 years in 9 geographic regions in Kenya. Participants answered questionnaires and provided blood for HIV testing. We estimated HIV prevalence, HIV incidence, described trends in HIV prevalence over the past 5 years, and identified factors associated with HIV infection. This analysis was restricted to persons aged 15-64 years. RESULTS: HIV prevalence was 5.6% [95% confidence interval (CI): 4.9 to 6.3] in 2012, a significant decrease from 2007, when HIV prevalence, excluding the North Eastern region, was 7.2% (95% CI: 6.6 to 7.9). HIV incidence was 0.5% (95% CI: 0.2 to 0.9) in 2012. Among women, factors associated with undiagnosed HIV infection included being aged 35-39 years, divorced or separated, from urban residences and Nyanza region, self-perceiving a moderate risk of HIV infection, condom use with the last partner in the previous 12 months, and reporting 4 or more lifetime number of partners. Among men, widowhood, condom use with the last partner in the previous 12 months, and lack of circumcision were associated with undiagnosed HIV infection. CONCLUSIONS: HIV prevalence has declined in Kenya since 2007. With improved access to treatment, HIV prevalence has become more challenging to interpret without data on new infections and mortality. Correlates of undiagnosed HIV infection provide important information on where to prioritize prevention interventions to reduce transmission of HIV in the broader population.
Authors: T C Quinn; M J Wawer; N Sewankambo; D Serwadda; C Li; F Wabwire-Mangen; M O Meehan; T Lutalo; R H Gray Journal: N Engl J Med Date: 2000-03-30 Impact factor: 91.245
Authors: Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Jennifer S Galbraith; Athanasius Ochieng; Samuel Mwalili; Donath Emusu; Zebedee Mwandi; Andrea A Kim; George Rutherford; William K Maina; Davies O Kimanga; Kipruto Chesang; Peter Cherutich Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: William K Maina; Andrea A Kim; George W Rutherford; Malayah Harper; Boniface O K'Oyugi; Shahnaaz Sharif; George Kichamu; Nicholas M Muraguri; Willis Akhwale; Kevin M De Cock Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Wanjiru Waruiru; Andrea A Kim; Davies O Kimanga; James Ng'ang'a; Sandra Schwarcz; Lucy Kimondo; Anne Ng'ang'a; Mamo Umuro; Mary Mwangi; James K Ojwang'; William K Maina Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Tom Oluoch; Ibrahim Mohammed; Rebecca Bunnell; Reinhard Kaiser; Andrea A Kim; Anthony Gichangi; Mary Mwangi; Sufia Dadabhai; Lawrence Marum; Alloys Orago; Jonathan Mermin Journal: Open AIDS J Date: 2011-12-30
Authors: Anne Ng'ang'a; Wanjiru Waruiru; Carol Ngare; Victor Ssempijja; Thomas Gachuki; Inviolata Njoroge; Patricia Oluoch; Davies O Kimanga; William K Maina; Rex Mpazanje; Andrea A Kim Journal: J Acquir Immune Defic Syndr Date: 2014-05-01 Impact factor: 3.731
Authors: Ishani Pathmanathan; Philip Lederer; Ray W Shiraishi; Nellie Wadonda-Kabondo; Anand Date; Blackson Matatiyo; E Kainne Dokubo Journal: Open Forum Infect Dis Date: 2016-12-15 Impact factor: 3.835
Authors: Rena Patel; Sarah Baum; Daniel Grossman; Rachel Steinfeld; Maricianah Onono; Craig Cohen; Elizabeth Bukusi; Sara Newmann Journal: AIDS Patient Care STDS Date: 2014-06-13 Impact factor: 5.078
Authors: Bernadette N Ng'eno; Timothy A Kellogg; Andrea A Kim; Anne Mwangi; Mary Mwangi; Joyce Wamicwe; George W Rutherford Journal: Int J STD AIDS Date: 2018-02-28 Impact factor: 1.359
Authors: Bernadette Ngeno; Anthony Waruru; Irene Inwani; Lucy Nganga; Evelyn Ngugi Wangari; Abraham Katana; Anthony Gichangi; Ann Mwangi; Irene Mukui; George W Rutherford Journal: J Adolesc Health Date: 2018-10-25 Impact factor: 5.012
Authors: Ann E Kurth; Charles M Cleland; Don C Des Jarlais; Helgar Musyoki; John A Lizcano; Nok Chhun; Peter Cherutich Journal: J Acquir Immune Defic Syndr Date: 2015-12-01 Impact factor: 3.731
Authors: Kathrine A Schilling; Alex O Awuor; Anu Rajasingham; Fenny Moke; Richard Omore; Manase Amollo; Tamer H Farag; Dilruba Nasrin; James P Nataro; Karen L Kotloff; Myron M Levine; Tracy Ayers; Kayla Laserson; Anna Blackstock; Richard Rothenberg; Christine E Stauber; Eric D Mintz; Robert F Breiman; Ciara E O'Reilly Journal: Am J Trop Med Hyg Date: 2018-10 Impact factor: 2.345